Breast cancer drug halves cases in high-risk women

A large landmark study funded by Cancer Research UK has found that the breast cancer drug anastrozole can halve the chances of developing the disease in high-risk women.The results of the IBIS II trial, led by Queen Mary University of London and published online in the The Lancet this week, show that in nearly 4,000 post-menopausal women at high risk of breast cancer, taking anastrozole for 5 years cut cases by 53%, compared with a placebo.
Source: Health News from Medical News Today - Category: Consumer Health News Tags: Breast Cancer Source Type: news